Jodi Devlin - Feb 18, 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: Chief of Clinical Operations
Signature: /s/ Sean Murphy, Attorney-in-Fact
Stock symbol: TLSI
Transactions as of: Feb 18, 2025
Transactions value $: $0
Form type: 4
Date filed: 2/19/2025, 05:37 PM
Previous filing: Jan 29, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TLSI	Common Stock	Award	$0	+5.27K	+18.74%	$0.00	33.4K	Feb 18, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Content

Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.